Avanzanite Bioscience B.V., a commercial-stage European specialty pharmaceutical company focused on rare diseases, has appointed Dr. Mark Bechter as Senior Vice President of Medical Affairs. In his role, Bechter will oversee all medical and scientific functions, including medical education, thought leader engagement, scientific communication, investigator-sponsored studies, evidence generation and medical information. Based in the UK, he will provide leadership and strategic direction across ...